Christopher Ryan Sullivan - Net Worth and Insider Trading
Christopher Ryan Sullivan Net Worth
The estimated net worth of Christopher Ryan Sullivan is at least $65 dollars as of 2024-11-05. Christopher Ryan Sullivan is the CFO of Avalo Therapeutics Inc and owns about 5 shares of Avalo Therapeutics Inc (AVTX) stock worth over $65. Details can be seen in Christopher Ryan Sullivan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Ryan Sullivan has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Ryan Sullivan
Christopher Ryan Sullivan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Ryan Sullivan owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of Christopher Ryan Sullivan’s form 4 insider trades.
Insider Ownership Summary of Christopher Ryan Sullivan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2023-06-09 | Interim CFO |
Christopher Ryan Sullivan Latest Holdings Summary
Christopher Ryan Sullivan currently owns a total of 1 stock. Christopher Ryan Sullivan owns 5 shares of Avalo Therapeutics Inc (AVTX) as of June 9, 2023, with a value of $65.
Latest Holdings of Christopher Ryan Sullivan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2023-06-09 | 5 | 13.01 | 65 |
Holding Weightings of Christopher Ryan Sullivan
Christopher Ryan Sullivan Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Ryan Sullivan has made a total of 4 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 2 shares on June 9, 2023, which cost Christopher Ryan Sullivan around $1,748.
Insider Trading History of Christopher Ryan Sullivan
- 1
Christopher Ryan Sullivan Trading Performance
GuruFocus tracks the stock performance after each of Christopher Ryan Sullivan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Ryan Sullivan is -36.97%. GuruFocus also compares Christopher Ryan Sullivan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Ryan Sullivan within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Ryan Sullivan's insider trading performs compared to the benchmark.
Performance of Christopher Ryan Sullivan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -37.65 | | | | | |
| Relative Return to S&P 500(%) | -39.03 | | | | | |
Christopher Ryan Sullivan Ownership Network
Ownership Network List of Christopher Ryan Sullivan
Ownership Network Relation of Christopher Ryan Sullivan
Christopher Ryan Sullivan Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Christopher Ryan Sullivan is the Interim CFO of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Chief Medical Officer Garry Arthur Neil .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Christopher Ryan Sullivan made 1 insider transaction in Avalo Therapeutics Inc (AVTX) with a net purchase of 511. Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 99,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 435 shares were bought by its insiders, resulting in a net sale of 14,913 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Christopher Ryan Sullivan Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Ryan Sullivan. You might contact Christopher Ryan Sullivan via mailing address: C/o Cerecor Inc., 400 E. Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
